72.11.Z - Scientific research and development activities
20.42.Z - Manufacture of cosmetics and toilet preparations
20.5 - Manufacture of other chemical products
20.53.Z - Manufacture of chemicals and chemical products
21.10.Z - Manufacture of basic pharmaceutical products
21.20.Z - Manufacture of pharmaceutical preparations and other pharmaceutical products
72.19.Z - Scientific research and development activities
2020 | 2021 | ||
---|---|---|---|
M PLN | M PLN | % | |
Gross profit (loss) | -1,4 | -1,3 | 6 |
EBITDA | -1,4 | -1,1 | 19,9 |
Short time liabilities | 0,2 | 0,3 | 27,2 |
Equity capital | 1,8 | 5,9 | 236,4 |
Operating profit (EBIT) | -1,4 | -1,2 | 15,4 |
Assets | 7,9 | 11,8 | 48,9 |
Net profit (loss) | -1,4 | -1,1 | 17,8 |
Cash | 6,9 | 9,7 | 41,8 |
Net income from sale | 0 | 0 | 0 |
Liabilities and provisions for liabilities | 6,2 | 5,8 | -4,9 |
Working assets | 7,6 | 11,1 | 46,3 |
Depreciation | 0 | 0,1 | 253,8 |
% | % | p.p. | |
Profitability of capital | -76,7 | -18,8 | 57,9 |
Equity capital to total assets | 22,3 | 50,4 | 28,1 |
Days | Days | Days | |
Short term commitment turnover cycle | 2 147 483 648 | 2 147 483 648 | 0 |
Current financial liquidity indicator | 1.2302379608154297 | 1.8935786485671997 | 0,7 |
Net dept to EBITDA | 4.890462398529053 | 8.659710884094238 | 3,8 |
Opinie dotyczące usług, produktów oraz działalności firmy nie są weryfikowane